Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Recruiting Phase 2 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0115747 (Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00801489Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeTreatment